Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
October 17, 2017
How Chi Sequence Modifies RecBCD Single-Stranded DNA Translocase Activity
Chia-Chuan Cho, Cinya Chung, Hung-Wen Li
Journal of Molecular Biology
|
January 16, 2022
The Pyrrolysyl-tRNA Synthetase Activity can be Improved by a P188 Mutation that Stabilizes the Full-Length Enzyme
Chia-Chuan Cho, Lauren R Blankenship, Xinyu Ma, et al.
Scientific Reports
|
November 4, 2017
Stable Nuclei of Nucleoprotein Filament and High ssDNA Binding Affinity Contribute to Enhanced RecA E38K Recombinase Activity
Chih-Hao Lu, Ting-Tzu Chang, Chia-Chuan Cho, et al.
Chemmedchem
|
February 8, 2022
Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
Chia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Chemmedchem
|
August 23, 2021
Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
Chia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Bepridil is potent against SARS-CoV-2 In Vitro
Erol C Vatansever, Kai Yang, Kaci C Kratch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2021
Bepridil is potent against SARS-CoV-2 in vitro
Erol C Vatansever, Kai S Yang, Aleksandra K Drelich, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors
Yuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease Inhibitors
Yugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry
|
July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
Yugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry
|
October 17, 2017
How Chi Sequence Modifies RecBCD Single-Stranded DNA Translocase Activity
Chia-Chuan Cho, Cinya Chung, Hung-Wen Li
Journal of Molecular Biology
|
January 16, 2022
The Pyrrolysyl-tRNA Synthetase Activity can be Improved by a P188 Mutation that Stabilizes the Full-Length Enzyme
Chia-Chuan Cho, Lauren R Blankenship, Xinyu Ma, et al.
Scientific Reports
|
November 4, 2017
Stable Nuclei of Nucleoprotein Filament and High ssDNA Binding Affinity Contribute to Enhanced RecA E38K Recombinase Activity
Chih-Hao Lu, Ting-Tzu Chang, Chia-Chuan Cho, et al.
Chemmedchem
|
February 8, 2022
Corrigendum: Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
Chia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Chemmedchem
|
August 23, 2021
Drug Repurposing for the SARS-CoV-2 Papain-Like Protease
Chia-Chuan Cho, Shuhua G Li, Tyler J Lalonde, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2020
Bepridil is potent against SARS-CoV-2 In Vitro
Erol C Vatansever, Kai Yang, Kaci C Kratch, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 18, 2021
Bepridil is potent against SARS-CoV-2 in vitro
Erol C Vatansever, Kai S Yang, Aleksandra K Drelich, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
The P3 <i>O</i> - <i>Tert</i> -Butyl-Threonine is Key to High Cellular and Antiviral Potency for Aldehyde-Based SARS-CoV-2 Main Protease Inhibitors
Yuying Ma, Kai S Yang, Zhi Zachary Geng, et al.
Biorxiv : the Preprint Server for Biology
|
January 4, 2022
The <i>N</i> -Terminal Carbamate is Key to High Cellular and Antiviral Potency for Boceprevir-Based SARS-CoV-2 Main Protease Inhibitors
Yugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
European Journal of Medicinal Chemistry
|
July 15, 2022
A systematic exploration of boceprevir-based main protease inhibitors as SARS-CoV-2 antivirals
Yugendar R Alugubelli, Zhi Zachary Geng, Kai S Yang, et al.
Page
of 2